Literature DB >> 1316084

Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations.

S A Halter1, P Dempsey, Y Matsui, M K Stokes, R Graves-Deal, B L Hogan, R J Coffey.   

Abstract

Eight lines of transgenic mice expressing a mouse mammary tumor virus (MMTV) human transforming growth factor-alpha (TGF alpha) fusion gene were established. Three lines with distinctive phenotypes are presented. All have proliferative changes of the mammary gland. One line has sebaceous gland hyperplasia of the skin. Five histologic patterns of mammary gland hyperplasia based on two of these lines were identified: cystic hyperplasia, solid hyperplasia, dysplasia, adenoma, and adenocarcinoma. Human TGF alpha mRNA and protein were produced in all patterns but appeared reduced in solid hyperplasia, dysplasia, and adenocarcinoma. TGF alpha immunoreactivity in the mammary tissue, cystic fluid, and serum did not show significant differences; hyperplasia developed in 65% of multiparous mice and 45% of virgin mice by 12 months of age. Adenocarcinoma developed in 40% of multiparous mice and 30% of virgin mice by 16 months of age. These transgenic lines may provide useful models of mammary and sebaceous gland hyperplasia analogous to human disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316084      PMCID: PMC1886506     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 2.  Transforming growth factor-alpha. A model for membrane-anchored growth factors.

Authors:  J Massagué
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

Review 3.  Too many rodent carcinogens: mitogenesis increases mutagenesis.

Authors:  B N Ames; L S Gold
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

4.  Expression of the TGF alpha integral membrane precursor induces transformation of NRK cells.

Authors:  A J Blasband; D M Gilligan; L F Winchell; S T Wong; N C Luetteke; K T Rogers; D C Lee
Journal:  Oncogene       Date:  1990-08       Impact factor: 9.867

Review 5.  Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis.

Authors:  S M Cohen; D T Purtilo; L B Ellwein
Journal:  Mod Pathol       Date:  1991-05       Impact factor: 7.842

Review 6.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

7.  Increased cell division as a cause of human cancer.

Authors:  S Preston-Martin; M C Pike; R K Ross; P A Jones; B E Henderson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

8.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

9.  TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

Authors:  C Jhappan; C Stahle; R N Harkins; N Fausto; G H Smith; G T Merlino
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

10.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

View more
  33 in total

Review 1.  Role of mesenchymal-epithelial interactions in mammary gland development.

Authors:  G R Cunha; Y K Hom
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

2.  Amphiregulin exosomes increase cancer cell invasion.

Authors:  James N Higginbotham; Michelle Demory Beckler; Jonathan D Gephart; Jeffrey L Franklin; Galina Bogatcheva; Gert-Jan Kremers; David W Piston; Gregory D Ayers; Russell E McConnell; Matthew J Tyska; Robert J Coffey
Journal:  Curr Biol       Date:  2011-04-21       Impact factor: 10.834

Review 3.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 4.  Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer.

Authors:  Margot P Cleary
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-12       Impact factor: 2.673

Review 5.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

6.  Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.

Authors:  B R Davies; A M Platt-Higgins; G Schmidt; P S Rudland
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

Authors:  D F Pierce; A E Gorska; A Chytil; K S Meise; D L Page; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 8.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 9.  Genetically modified laboratory mice with sebaceous glands abnormalities.

Authors:  Carmen Ehrmann; Marlon R Schneider
Journal:  Cell Mol Life Sci       Date:  2016-07-25       Impact factor: 9.261

10.  Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.

Authors:  Agnieszka E Gorska; Roy A Jensen; Yu Shyr; Mary E Aakre; Neil A Bhowmick; Harold L Moses
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.